Early endogenous activation of CB1 and CB2 receptors after spinal cord injury is a protective response involved in spontaneous recovery A Arevalo-Martin, D Garcia-Ovejero, Y Sierra-Palomares, ... PLOS one 7 (11), e49057, 2012 | 46 | 2012 |
Ligand chain length drives activation of lipid G protein-coupled receptors A Troupiotis-Tsaïlaki, J Zachmann, I González-Gil, A Gonzalez, ... Scientific reports 7 (1), 2020, 2017 | 42 | 2017 |
Structure–activity relationship of a new Series of reversible dual monoacylglycerol lipase/fatty acid amide hydrolase inhibitors JA Cisneros, E Björklund, I González-Gil, Y Hu, A Canales, FJ Medrano, ... Journal of medicinal chemistry 55 (2), 824-836, 2012 | 42 | 2012 |
A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration I González-Gil, D Zian, H Vázquez-Villa, G Hernández-Torres, ... Journal of medicinal chemistry 63 (5), 2372-2390, 2019 | 26 | 2019 |
The status of the lysophosphatidic acid receptor type 1 (LPA 1 R) I González-Gil, D Zian, H Vázquez-Villa, S Ortega-Gutiérrez, ... MedChemComm 6 (1), 13-23, 2015 | 22 | 2015 |
Development of ligands for the validation of the lysophosphatidic acid receptor LPA₁ I González Gil Universidad Complutense de Madrid, 0 | | |